TABLE 2.
PET/CT performance in treated cervix malignancy with unexplained tumor marker elevation (n=32)*
*Disease prevalence, 73.8% (23.4-62.3%). PET/CT: 18F-FDG PET/CT.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.